Camelot Biomedical Systems

What Camelot Biomedical Systems does

Camelot Biomedical Systems S.r.l. is an Italian private consulting and software development firm founded in 2009, headquartered in Genova with additional offices in Milano and Pescara. The company provides digital transformation solutions to Italian Public Administrations and enterprises, built on AI, Machine Learning, Blockchain, and Data Analytics technologies, with primary vertical focus on Digital Healthcare/Medical Devices (operating under ISO 13485 certification since 2014) and Industry 4.0/Manufacturing. Its product portfolio includes the VIP-TB platform for multidisciplinary tumor boards, the GUIDANCE agentic AI platform for pediatric congenital kidney and urinary tract anomaly diagnosis, the ROSSANA cybersecurity-as-a-service platform for biomedical equipment and IoMT devices, custom medical image processing software embedded in Esaote's ultrasound and MRI systems, plus predictive, energy, and port-monitoring platforms developed through European research projects.

The company operates a sales-led, project-based consulting model, delivering tailored turn-key solutions through direct engagements with public administration and enterprise clients. Revenue is generated primarily through professional services fees for consulting and development work, with supplemental one-time licensing revenue from medical device software. Camelot has secured over €16 million in cumulative EU and regional research grants across initiatives including TraDE-Opt (€3.77M), CTE Genova (€8.69M), EFFICACITY (€1.05M), ROSSANA, GUIDANCE, and VIP-TB. The company is co-founded and managed by four partners (Matteo Santoro, Curzio Basso, Mario Esposito, Sofia Mosci), with no external institutional investment disclosed. Anchor customers include ARIA SpA (innovation governance for Regione Lombardia) and Esaote (medical imaging equipment manufacturer), and the firm holds memberships in Confindustria Dispositivi Medici and Start 4.0 Competence Center.

Name

Camelot Biomedical Systems

Legal name

Camelot Biomedical Systems S.r.l.

Website

https://camelotbio.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Camelot Biomedical Systems is an Italian AI consulting and software development firm that builds digital healthcare, medical device software, and Industry 4.0 solutions for Italian public administrations and enterprises, leveraging machine learning, blockchain, and data analytics with ISO 13485 compliance.

Ownership category

akta.pro rank

Product category

Healthcare AI Software

NAICS

Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Decision Support & Workflow Automation (Protocols, Templates, AI Scribing) (HLAMAGAH)

akta.pro secondary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

Keywords

• Machine learning consulting
• Medical imaging software
• Digital healthcare solutions
• Industry 4.0 solutions
• Blockchain data analytics

Headquarters

HQ city

Genova

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Digital Transformation Consulting & Development: Support for Public Administrations and Enterprises in digital transformation process through design and development of turn-key solutions leveraging AI, Blockchain, and Data Analytics technologies
2. Medical Device Software Development: Design and development of image processing software integrated into medical diagnostic equipment (ultrasound and MRI devices)

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Camelot Biomedical Systems is an Italian innovative company that supports Public Administrations and Enterprises in digital transformation by designing and developing turn-key solutions leveraging AI, Machine Learning, Blockchain, and Data Analytics. It operates in highly technological sectors such as digital Healthcare (with custom image processing software integrated into ultrasound and MRI diagnostic devices) and Industry 4.0, and provides complete regulatory compliance support for medical device markets (EU MDR, ISO 13485).

Product overview

Camelot Biomedical Systems is a consulting and software development firm that provides AI, Machine Learning, Blockchain, and Data Analytics solutions primarily for Digital Healthcare and Industry 4.0 sectors. Their product portfolio includes specialized platforms for clinical decision support (VIP-TB, GUIDANCE), cybersecurity for medical devices (ROSSANA), medical image processing software integrated into diagnostic equipment, and predictive technology platforms. The company operates as a solution provider for Public Administrations and enterprises, including notable clients like ARIA Spa (innovation management for Lombardy Region) and Esaote (medical imaging software). They also develop custom AI solutions for smart cities, energy management, and environmental monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

• VIP-TB (Virtual Interdisciplinary Platform for Tumor Boards) Digital platform that supports multidisciplinary tumor boards in the breast cancer diagnostic and therapeutic process, providing unified access to images, clinical data, case preparation, documentation, and remote collaboration for clinical teams.
• GUIDANCE (Agentic AI Platform) Agentic AI platform that analyzes diagnostic images and electronic health records (EHR) to provide clinical decision support for pediatric diagnosis of congenital kidney and urinary tract anomalies (CAKUT), coordinated with IRCCS Giannina Gaslini.
• ROSSANA (Cyber Security Platform) Cybersecurity as a Service (CSaaS) and Equipment as a Service (EaaS) platform for securing legacy biomedical equipment and Internet of Medical Things (IoMT) devices, incorporating explainable and trustworthy AI.
• Predictive Technology Platform (AI-as-a-Service) Cloud-based predictive technology platform developed for the CTE Genova Digital Factory for Culture project, enabling museums and cultural institutions to leverage AI capabilities.
• EVERGRID Platform Digital platform enabling bidirectional communication between smart buildings, users, and local microgrids, providing tools for intelligent energy consumption and renewable resource management.
• TAPIN System Comprehensive intelligent system for port environments that uses computer vision and multi-source data analytics to monitor operations, security violations, and environmental factors.
• Digital Transformation Consulting & Development Services Professional consulting and software development services that support Public Administrations and Enterprises in their digital transformation process, including the design and development of turn-key solutions leveraging AI, Blockchain, and Data Analytics, with complete regulatory compliance support for medical device markets.

Quantifiable outcome

• €8.69M funded project for cultural heritage digitalization
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability12 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• GUIDANCE Project Consortium (IRCCS Giannina Gaslini, Dorian Technologies srl, SurgiQ srl, EBIT srl)coreStrategic or Co-development Partner · 1 February 2023Camelot Biomedical Systems coordinates the GUIDANCE project - an agentic AI platform supporting diagnosis and clinical decision-making for pediatric congenital kidney and urinary tract anomalies (CAKUT). Consortium includes IRCCS Giannina Gaslini (research hospital), Dorian Technologies (PMI), SurgiQ (PMI), and EBIT (GI). Project funded by P.R. FESR LIGURIA 2021-2027 with €599,994.21 contribution.
• Start 4.0 (Competence Center)coreStrategic or Co-development PartnerCamelot is a founding member of Start 4.0, a Competence Center for security and optimization of strategic infrastructures. The center focuses on enabling technologies for managing resilience and reliability of energy systems, ports, industrial areas and emergency services. Camelot contributes ML and Big Data Analytics expertise for developing predictive models.
• Confindustria Dispositivi MediciminorOthersCamelot Biomedical Systems is a member of Confindustria Dispositivi Medici (Medical Devices Industry Association), which requires annual publication of transparency reports on value transfers to Healthcare Professionals and Organizations.
• H2020 Research NetworkminorStrategic or Co-development PartnerActive participant in multiple Horizon 2020 projects including TraDE-Opt (MSCA-ITN) and NoMADS (MSCA-RISE), collaborating with international research consortiums for training and knowledge exchange in optimization and non-local methods.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Dedalus Group: European healthcare IT vendor providing clinical software, diagnostics, and SaMD platforms across hospitals and regions. Comparable to Camelot as a healthcare software provider serving regulated markets, but at much greater scale and broader portfolio.
• Engineering Group: Large Italian IT services and software provider with a healthcare practice serving public administrations and enterprises. Comparable as a domestic digital transformation partner with public-sector exposure, though far larger and more diversified than Camelot.
• Reply SpA: Italian digital services group with strong AI/ML and data analytics practices serving enterprises across Europe. Comparable to Camelot in technology stack (AI, data, cloud) and Italian origins, but operates at significantly larger scale and broader verticals.
• Capgemini Engineering: Global engineering and digital services arm of Capgemini with deep healthcare, AI, and embedded systems capabilities. Comparable as a provider of AI-driven medical and industrial software at scale, though operating globally and competing for the same regulated European SaMD work.

Direct peers

• GPI SpA: Italian healthcare and social-care IT group offering software for clinical workflows, laboratory management, and digital health. Directly comparable as an Italian-headquartered health-IT firm serving public administrations and healthcare providers with software and services.
• Exprivia SpA: Italian IT consulting and software company with a healthcare and public-sector focus, including AI/data analytics capabilities. Closely comparable as a domestic mid-sized IT firm delivering digital transformation and custom software to regulated Italian customers.

Regional players

• TXT e-solutions: Italian software and engineering services firm delivering AI/ML and digital engineering solutions to industrial and aerospace customers in Europe. Comparable as a mid-sized Italian boutique engineering/AI consultancy, though more weighted to industrial than healthcare.
• Lutech Group: Italian IT services and cloud/AI consultancy serving enterprises and public sector. Comparable as a domestic Italian systems integrator with AI/data capabilities, though not specialized in healthcare or medical-device compliance.

Emerging players

• Arterys: Medical imaging AI company providing cloud-based diagnostic imaging analytics integrated into clinical workflows. Comparable to Camelot's medical imaging AI work for Esaote, though focused on cloud-native SaaS rather than embedded OEM software.

Others

• Esaote SpA: Italian diagnostic imaging OEM and key Camelot customer. Included as an ecosystem participant rather than a competitor — understanding Esaote helps frame Camelot's addressable channel and the strategic value of its embedded software.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Camelot Biomedical Systems